Effects of Cannabinoids on Dopamine Release in the Corpus Striatum and the Nucleus Accumbens In Vitro

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Neurochemistry

• Publication date

  1999-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1046/j.1471-4159.1999.0731084.xPMID 10461898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells.

  2006cited by this paper
• D3 dopamine receptor mRNA is widely expressed in the human brain.

  1998cited by this paper
• Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice.

  1998cited by this paper
• Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum.

  1998cited by this paper
• Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.

  1998cited by this paper
• Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors.

  1998cited by this paper
• Influence of Cannabinoids on Electrically Evoked Dopamine Release and Cyclic AMP Generation in the Rat Striatum

  1997influential reference
• Electrically‐evoked dopamine and acetylcholine release from rat striatal slices perfused without magnesium: regulation by glutamate acting on NMDA receptors

  1997cited by this paper
• Effects of chronic exposure to Δ9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions

  1997influential reference
• Pharmacology of cannabinoid CB1 and CB2 receptors.

  1997cited by this paper
• Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.

  1997influential reference
• Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.

  1997cited by this paper
• Cannabinoid receptor-mediated inhibition of dopamine release in the retina

  1996cited by this paper
• Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

  1996cited by this paper
• Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder

  1996cited by this paper
• Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems.

  1996cited by this paper
• Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications.

  1995cited by this paper
• Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.

  1995cited by this paper
• Pharmacology of cannabinoid receptors.

  1995influential reference
• Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.

  1993cited by this paper
• Localization of cannabinoid receptor mRNA in rat brain

  1993cited by this paper
• Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea‐pig small intestine

  1992cited by this paper
• Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles.

  1992cited by this paper
• Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry.

  1992cited by this paper
• Presynaptic regulation of electrically evoked dopamine overflow in nucleus accumbens: a pharmacological study using fast cyclic voltammetry in vitro

  1991cited by this paper
• Pharmacological profile of various κ‐agonists at κ‐, μ‐ and δ‐opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain

  1991cited by this paper
• Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

  1991cited by this paper
• “Real time” measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens : role of autoinhibition

  1991cited by this paper
• Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.

  1991cited by this paper
• Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.

  1990cited by this paper
• Modulation of neurotransmitter release by presynaptic autoreceptors.

  1989cited by this paper

• Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density

  2023cites this paper
• Plasma endocannabinoids in cocaine dependence and their interaction with cocaine craving and metabotropic glutamate receptor 5 density in the human brain

  2023cites this paper
• Synthetic cannabinoids (SC)

  2022cites this paper
• Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice

  2022cites this paper
• Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge

  2022cites this paper
• Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain

  2022cites this paper
• CB1R activation in nucleus accumbens core promotes stress-induced reinstatement of cocaine seeking by elevating extracellular glutamate in a drug-paired context

  2021cites this paper
• The effects of nabilone and dexamphetamine on three underlying schizotypy dimensions of delusions/hallucinations, mania and delusional guilt

  2021cites this paper
• Cocaine-induced increases in motivation require 2-arachidonoylglycerol mobilization and CB1 receptor activation in the ventral tegmental area.

  2021cites this paper
• Impairment of Synaptic Plasticity by Cannabis, Δ9-THC, and Synthetic Cannabinoids.

  2020cites this paper
• Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal

  2020cites this paper
• Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis

  2020cites this paper
• Modulatory effects of cannabinoids on brain neurotransmission

  2019cites this paper
• Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis

  2019cites this paper
• Metabolomics-Coupled Functional Pharmacology of Chlorophyll Compounds Isolated From the Leaves of Ficus Exasperata Vahl (Moraceae) Provides Novel Pathways on Myometrial Activity

  2018cites this paper
• Bafor, Enitome E. and Rowan, Edward G. and Edrada-Ebel, RuAngelie (2017) Metabolomics-coupled functional pharmacology of chlorophyll compounds isolated from the leaves of Ficus Exasperata Vahl

  2018cites this paper
• Role of the endocannabinoid system in drug addiction.

  2018cites this paper
• Delta‐9‐tetrahydrocannabinol potentiates fear memory salience through functional modulation of mesolimbic dopaminergic activity states

  2018cites this paper
• Endocannabinoid modulation of dopamine neurotransmission

  2017cites this paper
• The Endocannabinoid System and Parkinson Disease

  2017cites this paper
• Endocannabinoid-Dependent Synaptic Plasticity in the Striatum

  2017cites this paper
• Psychostimulant Effect of the Synthetic Cannabinoid JWH-018 and AKB48: Behavioral, Neurochemical, and Dopamine Transporter Scan Imaging Studies in Mice

  2017cites this paper
• Cannabis: A Treasure Trove or Pandora's Box?

  2017cites this paper
• Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens.

  2017cites this paper
• Amphetamine elevates nucleus accumbens dopamine via an action potential‐dependent mechanism that is modulated by endocannabinoids

  2016cites this paper
• The Pharmacological Basis of Cannabis Therapy for Epilepsy

  2016cites this paper
• Striatal dopamine neurotransmission: regulation of release and uptake.

  2016cites this paper
• Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats.

  2016cites this paper
• Cannabinoids and Huntington’s disease

  2015cites this paper
• Interactions of Cannabis and Amphetamine-Type Stimulants

  2015cites this paper
• Distribution of the Endocannabinoid System in the Central Nervous System.

  2015cites this paper
• The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food

  2014cites this paper
• Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review.

  2014cites this paper
• Cannabinoids and levodopa-induced dyskinesia

  2014cites this paper
• Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone?

  2014cites this paper
• Acute and chronic effects of cannabinoids on human brain: gene-environment interactions related to psychiatric disorders

  2014cites this paper
• Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices.

  2013cites this paper
• Synthetic Cannabinoid Receptor Agonists

  2013cites this paper
• Dopamine Modulates Corticostriatal Inputs During Motor Command Signalilng

  2013cites this paper
• THC-MEDIATED INDUCTION OF ΔFOSB AND ITS MODULATION OF CB1R SIGNALING AND ADAPTATION

  2013cites this paper
• Delineation of Domains Within the Cannabinoid CB1 and Dopamine D2 Receptors That Mediate the Formation of the Heterodimer Complex

  2013cites this paper
• Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders

  2013cites this paper
• Synthetische Cannabinoide

  2012cites this paper
• Differential Treatment Regimen-Related Effects of HU210 on CB1 and D2-Like Receptor Functionality in the Rat Basal Ganglia

  2012cites this paper
• Chronic Delta-9-tetrahydrocannabinol Induces Monoamine Release but Not Conditioned Place Preference

  2012cites this paper
• Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo.

  2012cites this paper
• Classification of H₂O₂as a neuromodulator that regulates striatal dopamine release on a subsecond time scale.

  2012cites this paper
• Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors.

  2012cites this paper
• Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders.

  2012cites this paper
• Estudio psicofarmacológico de la modulación del sistema cannabinoide y su implicación neurocomportamental en la adicción a cocaína

  2011cites this paper
• Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex.

  2011cites this paper
• Dopamine release in the basal ganglia.

  2011cites this paper
• Endocannabinoid Signaling in the Striatum

  2010cites this paper
• Dürtüselliğin Nöroanatomik ve Nörokimyasal Temelleri Neuroanatomical and Neurochemical Basis of Impulsivity

  2010cites this paper
• Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

  2010cites this paper
• Cannabinoid receptors in the 3D reconstructed mouse brain: Function and regulation

  2010cites this paper
• Regulation of Extracellular Dopamine: Release and Uptake

  2010cites this paper
• Agonism of the endocannabinoid system modulates binge-like alcohol intake in male C57BL/6J mice: involvement of the posterior ventral tegmental area.

  2009cites this paper
• Role of endocannabinoid system in mental diseases

  2009cites this paper
• Stress-related factors in cannabis use and misuse: implications for prevention and treatment.

  2009cites this paper
• Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens.

  2009influential citation
• Neurosystems linking corticolimbic and hypothalamic pathways in energy balance: view from the Chair

  2009cites this paper
• Dopamine D3 Receptor Antagonist SB-277011A Influences Cell Firing in the Rat Ventral Tegmental Area, Parallel Role with the Cannabinoid System in Addiction and Neuropsychiatry Disorders?

  2009cites this paper
• D2 receptor‐mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: studies using fast cyclic voltammetry

  2009cites this paper
• Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.

  2008cites this paper
• Acute effects of the cannabinoid receptor agonist WIN55212-2 on dopamine release in rat: an in vivo electrochemical study.

  2008cites this paper
• Molecular mechanisms underlying the actions of psychoactive drugs in the basal ganglia : Focus on cannabinoids and morphine

  2008cites this paper
• Cannabinoids and the brain

  2008cites this paper
• The CB(1) cannabinoid receptor antagonist AM251 attenuates amphetamine-induced behavioural sensitization while causing monoamine changes in nucleus accumbens and hippocampus.

  2008cites this paper
• Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels.

  2008influential citation
• The Endocannabinoid System in the Physiology and Pathology of the Basal Ganglia

  2008cites this paper
• Involvement of subthalamic nucleus in the stimulatory effect of Delta(9)-tetrahydrocannabinol on dopaminergic neurons.

  2008cites this paper
• Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.

  2008cites this paper
• Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.

  2007cites this paper
• Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats

  2007cites this paper
• CB1‐independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum

  2007cites this paper
• Analogs of SR-141716A (Rimonabant) alter d-amphetamine-evoked [3H] dopamine overflow from preloaded striatal slices and amphetamine-induced hyperactivity.

  2007cites this paper
• The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.

  2007cites this paper
• Diferentes respostas reforçadoras e locomotoras induzidas pela ativação de endocanabinóide em ratos adolescentes e adultos das linhagens Wistar e Shr

  2007cites this paper
• HETEROMERIZACIÓN DE RECEPTORES DE ADENOSINA A2A, DOPAMINA D2 Y CANNABINOIDES CB1. IMPLICACIONES FARMACOLÓGICAS Y FUNCIONALES.

  2007cites this paper
• Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.

  2007cites this paper
• Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate

  2007cites this paper
• The Endocannabinoid System

  2006cites this paper
• Chronic treatment with Δ‐9‐tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats

  2006cites this paper
• Analysis of the effects of cannabinoids on identified synaptic connections in the caudate‐putamen by paired recordings in transgenic mice

  2006cites this paper
• An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments.

  2006cites this paper
• Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum: A Combined Immunochemical and Pharmacological Analysis

  2005cites this paper
• Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction.

  2005influential citation
• Cannabinoid control of motor function at the basal ganglia.

  2005cites this paper
• Role of the endocannabinoid system in the development of tolerance to alcohol.

  2005influential citation
• Endocannabinoid signaling system and brain reward: emphasis on dopamine.

  2005cites this paper
• Endocannabinoids and Dopamine-Related Functions in the CNS

  2005cites this paper
• Role of lipids and lipid signaling in the development of cannabinoid tolerance.

  2005cites this paper
• Molecular Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum : A Combined Immunochemical and Pharmacological Analysis

  2005cites this paper
• Effects of cannabinoids on neurotransmission.

  2005cites this paper
• CB1 Receptor Knockout Mice Display Reduced Ethanol-Induced Conditioned Place Preference and Increased Striatal Dopamine D2 Receptors

  2005cites this paper
• Distribution of cannabinoid receptors in the central and peripheral nervous system.

  2005cites this paper
• A role for endocannabinoids in the generation of parkinsonism and levodopa‐induced dyskinesia in MPTP‐lesioned non‐human primate models of Parkinson's disease

  2005cites this paper
• Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk?

  2005cites this paper
• Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain

  2004cites this paper